These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11409909)
21. Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis. Pruneri G; Alietti A; Agnelli L; Morabito F; Laszlo D; Calabrese L; Fabris S; Bertolini F; Agazzi A; Bottiglieri L; Raviele PR; Baldini L; Pileri S; Sabattini E; Bosari S; Maisonneuve P; Lambertenghi-Deliliers G; Bertoni F; Martinelli G; Viale G; Neri A Leuk Res; 2008 Oct; 32(10):1628-32. PubMed ID: 18355918 [No Abstract] [Full Text] [Related]
22. A kinder, gentler way: control of the proliferative tumor compartment, not cosmetic complete response, should be the goal of myeloma therapy. Bergsagel PL Leukemia; 2008 Apr; 22(4):673-5. PubMed ID: 18414492 [No Abstract] [Full Text] [Related]
26. Clinical and laboratory features of newly diagnosed multiple myeloma: a retrospective, single-centre analysis. Mai YJ; Qi PJ; Xu Y; Zou DH; Wang YF; Zhao YZ; Yang RC; Xiao ZJ; Qiu LG Chin Med J (Engl); 2007 Oct; 120(19):1727-9. PubMed ID: 17935680 [No Abstract] [Full Text] [Related]
27. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software. Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277 [TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance. Schilling G; Dierlamm J; Hossfeld DK Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296 [TBL] [Abstract][Full Text] [Related]
29. Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma. Depil S; Mathiot C; Leleu X; Moreau AS; Faucompré JL; Hennache B; Bauters F; Bataille R; Facon T Br J Haematol; 2005 Jun; 129(5):706-7. PubMed ID: 15916694 [No Abstract] [Full Text] [Related]
30. [From clinical tests to etiology: analysis of clinical features. Findings of new clinical features in laboratory tests]. Kitamura M Rinsho Byori; 1987 Dec; Spec No 75():27-33. PubMed ID: 3448281 [No Abstract] [Full Text] [Related]
31. Acid gel reaction--a rapid and inexpensive laboratory test for the diagnosis of multiple myeloma, and its correlation with immunoglobulins. Kate SL; Mutalik GS; Bapat JP; Baxi AJ J Assoc Physicians India; 1973 Aug; 21(8):693-6. PubMed ID: 4793015 [No Abstract] [Full Text] [Related]
32. Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status. Yeh HS; Chen H; Manyak SJ; Swift RA; Campbell RA; Wang C; Li M; Lee HJ; Waterman G; Gordon MS; Ma J; Bonavida B; Berenson JR Br J Haematol; 2006 Jun; 133(5):526-9. PubMed ID: 16681640 [TBL] [Abstract][Full Text] [Related]
33. New mitogens in cultures for multiple myeloma cytogenetic analysis. López de Frutos L; Álvarez Y; Armengol G; Caballín MR Leuk Lymphoma; 2013 Nov; 54(11):2548-50. PubMed ID: 23418873 [No Abstract] [Full Text] [Related]
34. Minimal residual disease monitoring in multiple myeloma. Davies FE; Rawstron AC; Owen RG; Morgan GJ Best Pract Res Clin Haematol; 2002 Mar; 15(1):197-222. PubMed ID: 11987924 [TBL] [Abstract][Full Text] [Related]
35. Conventional diagnostics in multiple myeloma. San Miguel JF; Gutiérrez NC; Mateo G; Orfao A Eur J Cancer; 2006 Jul; 42(11):1510-9. PubMed ID: 16762540 [TBL] [Abstract][Full Text] [Related]
36. Cytogenetics helps determine diagnosis and prognosis for multiple myeloma. Becze E ONS Connect; 2012 Dec; 27(12):18-9. PubMed ID: 23304802 [No Abstract] [Full Text] [Related]
37. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Schmidt-Wolf IG; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G Cancer Genet Cytogenet; 2006 May; 167(1):20-5. PubMed ID: 16682281 [TBL] [Abstract][Full Text] [Related]
39. [The role of the magnetic resonance in diagnosis of multiple myeloma]. Dytfeld D; Sosnowski P; Czyz A; Komarnick M Pol Merkur Lekarski; 2007 Aug; 23(134):85-8. PubMed ID: 18044333 [TBL] [Abstract][Full Text] [Related]
40. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization. Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]